What's driving Healthcare Artificial Intelligence Market ; Eminent Players - AiCure, APIXIO, Inc., Atomwise, Inc., Butterfly Network, Inc., Cyrcadia Health Inc., Enlitic, Inc., IBM (Watson Health), iCarbonX, Insilico Medicine, Inc., Lifegraph, Modernizing

Healthcare Artificial Intelligence Market size is set to exceed USD 13 billion By 2025; according to a new research report by Global Market Insights.
Rising adoption of healthcare artificial intelligence solutions and software in research processes and drug development will foster industry growth in near future. Current drug discovery process is witnessing a paradigm shift to meet the growing needs of society and patients. Advancements in clinical research and personal digital assistants have shown incredible potential of artificial intelligence technology over the recent decade. The use of artificial intelligence and its broadening horizons in research areas is likely to drive the AI in healthcare market. In drug research, use of artificial intelligence streamlines selection process of drug development and helps investigators to study only those drugs that are promising and aids in identification of previously undiscovered pathways escalating its adoption amongst the researchers and scientists proving beneficial for the industry growth.

Growing applications of healthcare artificial intelligence software and solutions will positively influence the industry growth. Promising application of artificial intelligence in the future includes image recognition to analyze large sets of MRI and CT scans to identify and diagnose malignant tumors with more accuracy than expert radiologists. Moreover, the application of artificial intelligence for assisting and monitoring patients with their needs in the absence of clinical professionals will also augment the industry growth.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1557

Wearables segment was valued at USD 99.3 million in 2018 and is expected to have considerable revenue size during the forecast timeframe. Increasing adoption of artificial intelligence, big data and machine learning tools in wearables to provide insights and make effective clinical decisions will foster its adoption amongst adults. Also, development of technologically advanced wearables that utilizes machine learning to identify significant changes in the patient’s vital parameters that allows caregivers to deliver quality care will prove beneficial for the segmental growth.

Europe AI in healthcare market witnessed 41.8% growth throughout the analysis period. Adoption of artificial intelligence in research areas and advancement in technology with respect to electronic health records (EHR) and eHealth should drive healthcare artificial intelligence market in Europe. Moreover, European Union undertakes several efforts to stimulate use of healthcare artificial systems to make eHealth stronger. European Union also introduced an innovative technology to develop EHR across Europe named as the European Health Records Organization (EHRO). Thus, efforts undertaken by government authorities will significantly impact the regional industry growth.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1557

Asia Pacific AI in healthcare market was valued at 148.9 million in 2018. Considerable revenue size can be attributed to the rising adoption of healthcare artificial intelligence software and solutions in maintaining large amount of patient data base. Emerging countries have huge population and it becomes difficult to secure the patient data that is vulnerable to several threats. Hence, availability of software and solutions that assures data integrity and security have increased its adoption amongst the healthcare professionals thereby, fostering the regional market growth.

Prominent industry players functioning in the healthcare artificial intelligence market include AiCure, APIXIO, Inc., Atomwise, Inc., Butterfly Network, Inc., Cyrcadia Health Inc., Enlitic, Inc., IBM (Watson Health), iCarbonX, Insilico Medicine, Inc., Lifegraph, Modernizing Medicine, Pathway Genomics Corporation, Sense.ly, Sophia Genetics, Welltok and Zebra Medical Vision Ltd. These players involved in healthcare artificial intelligence industry implement certain strategic initiatives such as collaborations, acquisitions, new product launch, mergers, partnerships, and geographical expansions that will allow the companies to sustain market position. For instance, in July 2016, Apixio introduced Compliance Auditor, first of its kind in the market, allows health plan to perform thorough quality assurance of outsourced risk adjustment chart coding. Introduction of such new platforms will enhance company’s software offerings and boost its revenue generation.

Healthcare artificial intelligence market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2014 to 2025, for the following segments:
AI in Healthcare Market, By Application (USD Million)
o Medical Imaging & Diagnosis
o Drug Discovery
o Therapy Planning
o Hospital Workflow
o Wearables
o Virtual Assistants
o Others
The above information is provided for the following regions and countries:
• North America
o U.S.
o Canada
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Sweden
o Netherlands
• Asia Pacific
o China
o Japan
o India
o Australia
o Singapore
• Latin America
o Brazil
o Mexico
• Middle East Asia & Africa
o South Africa
o Saudi Arabia

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Blog : http://news-researchers.com/

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

This release was published on openPR.